Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
letter
. 2021 Sep 15;5(10):e40. doi: 10.1016/S2352-4642(21)00266-2

Risk factors for COVID-19 mortality in hospitalised children and adolescents in Brazil

Siyu Chen a, Yong Shao a
PMCID: PMC8443227  PMID: 34536363

We read the Article by Eduardo Oliveira and colleagues1 with great interest and believe the findings from this cohort study are important, given that they directly investigated the risk factors associated with COVID-19 in children and adolescents.

In their study, patients were roughly evenly distributed among the three age groups, and risk of death was increased in infants younger than age 2 years and in adolescents aged 12–19 years, relative to children aged 2–11 years. However, the authors did not provide a rationale for the age groupings. The lower age limit of adolescence is generally defined as 10 years,2 including by the UN and WHO.3 Additionally, a study of COVID-19 trends between March 1, 2020, and Dec 12, 2020, in young people aged 0–24 years in the USA found that more than 81% of patients were older than 10 years.4 Therefore, we are interested to know how a different age stratification (<2 years, 2–9 years, and 10–19 years) would affect the study findings, and we believe that comparison between these age groups could provide further insight on the COVID-19 mortality risk in adolescents.

It is important to present the median and mean ages in the three age groups, given that this information will help readers understand how mortality risk is influenced by age within the broad age bands. Having data related to symptoms, comorbidities, admission to intensive care units, and death rate by age groups will also provide a basis for understanding the disparity in death risk among age groups.

The upper-age definition of adolescence has long posed a conundrum and varies across countries. Defining adolescence as age 10–24 years has been proposed to align more closely with adolescents’ biological growth and social-role transitions,2 and some studies on COVID-19 have included patients aged 0–24 years.4 The study by Oliveira and colleagues1 included patients younger than 20 years, and the inclusion of patients aged 21–24 years might provide a more comprehensive understanding of COVID-19 in adolescence.

We declare no competing interests.

References


Articles from The Lancet. Child & Adolescent Health are provided here courtesy of Elsevier

RESOURCES